Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a ...
Scientists have uncovered promising clues that compounds found in Aloe vera could play a role in fighting Alzheimer’s disease. Using advanced computer modeling, researchers discovered that ...
By far the strongest genetic risk factor for Alzheimer’s disease is a variant of apolipoprotein E, or ApoE. People who carry ...
Scientists have made a breakthrough in understanding how Alzheimer’s disease develops, and a decades-old drug could be the ...
ScienceAlert on MSN
Memory Loss in Alzheimer's Linked to Problems With The Brain's 'Replay Mode'
To consolidate memories, our brains replay them during periods of rest as a kind of 'replay mode'. A new mouse study suggests ...
There’s so much to process after an Alzheimer’s diagnosis. Whether it’s you or a loved one who has this disease, you’re likely working through piles of complicated information, an avalanche of ...
The research found that mice with Alzheimer's disease symptoms improved when a certain brain protein was suppressed.
Scientists have found that the anti-seizure medication levetiracetam prevents the buildup of faulty amyloid-beta proteins in the brain, which could help prevent Alzheimer's disease.
News-Medical.Net on MSN
Alzheimer’s plaques decline after CAR-T immune cell treatment in preclinical study
By Hugo Francisco de Souza A novel CAR-T cell approach targets amyloid plaques in preclinical Alzheimer models, raising the ...
Tim Sandry has an early form of Alzheimer’s disease, but considers himself fortunate to have started treatment with a promising new drug. “If there is a chance this will slow the progression, that’s ...
The Times of Israel on MSN
In world first, Israeli researchers use blood cancer treatment for Alzheimer’s in mice
Weizmann and Washington U. scientists harness CAR T-cell therapy to fight brain tissue inflammation in mice, potentially ...
In 2020, as many as 5.8 million Americans were living with Alzheimer’s Disease (AD)—a number projected to nearly triple to 14 million people by 2060. 1 As changes in the brain can begin years before ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results